Evidence map›Paper›PMID 36227382›Full record

ArticleInternational orthopaedics2023

Enhanced recovery after surgery for primary total hip arthroplasty: analysis of post-operative blood indexes.

Xiaoguang Wang, Yinyin Chen, Jianzong Zhao, Bo Wang, Zhiping Chen

Abstract read
PubMed Publisher
In one paragraph

Article in International orthopaedics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 3 pooled it
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 3 syntheses or guidelines pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Xiaoguang WangOrthopedics, Affiliated Hospital of Jiangsu University, Zhenjiang, 212000, China.
Yinyin ChenOrthopedics, Affiliated Hospital of Jiangsu University, Zhenjiang, 212000, China.
Jianzong ZhaoOrthopedics, Affiliated Hospital of Jiangsu University, Zhenjiang, 212000, China.
Bo WangOrthopedics, Affiliated Hospital of Jiangsu University, Zhenjiang, 212000, China.
Zhiping ChenOrthopedics, Taizhou Second People's Hospital, Taizhou, 225500, China. 1304469748@qq.com.ORCID http://orcid.org/0000-0001-9363-9011
Jiangsu University · CNTaizhou Second People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionTo explore the clinical efficacy of the enhanced recovery after surgery (ERAS) program in terms of blood management for primary hip arthroplasty patients.

methodNinety cases of total hip arthroplasty in our hospital from October 2020 to January 2022 were selected as the research objects, 45 cases as the control group, and 45 cases as the ERAS group. The control group was given routine care after operation, while the ERAS group was given ERAS management. The leucocytes, haemoglobin, platelets, albumin, D-dimer, C-reactive protein (CRP), total length of stay (LOS), and estimated blood loss after operation were compared between the two groups.

resultsThe results showed that the Hb, TPO, and Alb of the ERAS group before operation, one day and three days after operation were significantly higher than those of the control group (P < 0.05). The WBC, CRP, and D-dimer in ERAS group were significantly lower than those in the control group (P < 0.05). The LOS in ERAS group was significantly less than that in control group (P < 0.05). DISCUSSION: ERAS scheme can reduce the loss of blood and nutrients from surgery in patients. WBC, CRP, and D-dimer in ERAS group were significantly lower than those in the control group. Humane care from ERAS programs can relieve patients' anxiety to some extent.

conclusionERAS management contributes to the recovery of hip function in patients undergoing THA, reduces blood loss during peri-operative period, and reduces the effect of operation on blood system.

Indexed as

Arthroplasty, Replacement, HipEnhanced Recovery After SurgeryC-Reactive ProteinHumansLength of StayPostoperative ComplicationsTreatment OutcomeC-Reactive ProteinBlood indexesERASJoint surgeryLength of stayTotal hip arthroplasty

Identifiers

PMID36227382
OpenAlexW4306155548

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.